Investor Icahn School Of Medicine At Mount Sinai
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Icahn School Of Medicine At Mount Sinai . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-07-18 13G MGRM / Monogram Technologies Inc. 2,360,304
2025-02-21 13D/A SMFR / Sema4 Holdings Corp - Class A 1,373,569
2025-02-18 13D/A SMFR / Sema4 Holdings Corp - Class A 2,719,692 1,680,016
2024-11-19 13D/A SMFR / Sema4 Holdings Corp - Class A 2,866,833 2,719,692
2024-11-05 13D/A RNLXY / Renalytix Plc - Depositary Receipt (Common Stock) 22,286,727 35,653,477
2024-11-04 13D/A SMFR / Sema4 Holdings Corp - Class A 123,176,901 2,866,833
2024-04-26 13D/A RNLXY / Renalytix Plc - Depositary Receipt (Common Stock) 12,926,353 22,286,727
2023-11-27 13G HSCS / HeartSciences Inc. 4,854,853
2023-02-10 13D RNLXY / Renalytix Plc - Depositary Receipt (Common Stock) 10,161,375 12,926,353
2023-02-06 13D/A SMFR / Sema4 Holdings Corp - Class A 94,605,473 123,176,901
2022-05-27 13G/A / RENALYTIX AI PLC-ADR DEPOSITARY RECEIPT 10,161,375
2022-05-27 13G / RENALYTIX AI PLC-ADR DEPOSITARY RECEIPT 9,057,927
2022-05-06 13D/A SMFR / Sema4 Holdings Corp - Class A 88,355,473 94,605,473
2022-01-21 13D/A SMFR / Sema4 Holdings Corp - Class A 88,355,473 88,355,473
2021-10-13 13D SMFR / Sema4 Holdings Corp - Class A 88,355,473